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A B S T R A C T   
Mural ameloblastoma is a subtype of Unicystic Ameloblastoma characterised by the expansion or 
infiltration of tumour nodules into the fibrous wall of the cyst. The behaviour of this subtype is 
highly aggressive, with a risk of recurrence comparable with that of Conventional Amelo-
blastoma. Consequently, the preferred treatment for Unicystic mural Ameloblastom is broad 
resection of the tumour. In this case report we describe the successful conservative treatment of a 
Unicystic mural Ameloblastom associated with an impacted tooth. The conservative treatment 
consinsted in a initial marsupialization followed by the enucleation of the lesion performed with a 
lateral corticotomy to create a “bone door” and the relocation of the “bone door” using micro-
plates and titanium screws. 
Our conservative approach preserved the integrity of the inferior alveolar nerve as well as 
mandibular functionality and resulted in a good aesthetic outcome. 
Due to the behaviour of this lesion, a strict follow up is mandatory. In our experience, follow-up 
is conducted as long as possible regardless of the surgical treatment. This protocol includes Cone 
Beam CT performed 1 year after surgery and panoramic radiology (OPG) once a year until 5 years 
after surgery. OPG is then repeated every 3 years in patients with Unicystic Ameloblastoma and 
every 2 years in those with Conventional Ameloblastoma or ameloblastoma with mural invasion. 
Suspected recurrence should be evaluated by CBCT.   
1. Introduction 
Ameloblastoma is a benign tumour of epithelial origin. It is locally aggressive, increases to large volumes and has a high risk of 
recurrence. The most common variants are conventional ameloblastoma (CA) and unicystic ameloblastoma (UA). CA is the most 
aggressive form and has a tendency of recurring multiple times, whereas UA is a peculiar subtype distinguished by a more benign, less 
aggressive behaviour [1]. 
In 1988, Ackermann [2] divided UAs into three growth patterns: luminal, intraluminal and mural. In the intraluminal subtype, the 
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ameloblastic node protrudes from the cystic border into the lumen. In the luminal variant, the tumour node are contained within the 
ameloblastic cystic surface, and mural ameloblastomas are characterised by the expansion or infiltration of tumour nodules into the 
fibrous wall of the cyst. 
The intraluminal and luminal variants are considered to be less aggressive and to have a lower risk of recurrence, whereas the mural 
subtype is highly aggressive, with a risk of recurrence comparable with that of CA. The behaviour of the mural subtype is supported by 
the study by Li et al. [3], in which high levels of proliferating cell nuclear antigen and Ki-67 antigen were found in mural amelo-
blastomas. These findings are consistent with the ability of tumour islands in the fibrous wall to invade the surrounding cancellous 
bone. Consequently, the preferred treatment for mural UA is broad resection of the tumour [4,5]. 
However, in this case report we describe the successful conservative treatment of a mural UA associated with an impacted tooth. 
Our conservative approach preserved the integrity of the inferior alveolar nerve (IAN) as well as mandibular functionality and resulted 
in a good aesthetic outcome. 
2. Case presentation 
A 31-year-old male arrived at our clinic complaining of facial deformity, intraoral mandibular swelling and biting-related ulcers 
since the previous month. The patient reported neither pathologies nor allergies. 
Panoramic radiography (OPG) revealed absence of the medial portion of the mandibular ramus with interruption of the mandibular 
canal and impaction of tooth 4.8. Cone beam CT (CBCT) showed the amplitude of the lesion and cortical bone loss on both the lingual 
and buccal sides, as well as thinning of the bone base. In addition, the canal of the IAN was compromised (Fig. 1A). 
The preliminary diagnosis was odontogenic cyst or ameloblastoma.A small portion of the cystic wall was harvested for histological 
examination (sample size 0.8x0.6  0.5 cm). The cystic membrane was marsupialised and a gauze was placed in the cavity to maintain 
patency (Fig. 2). 
During the first postoperative month, the surgical site was rinsed weekly and then the patient was followed-up monthly at the 
clinic. 
Fig. 1. Radiographic images of the Unicystic Ameloblastoma (UA): A) CBCT scans at the diagnostic phase: cortical bone loss on both the lingual and 
buccal side is evident, as well as thinning of the basal bone. In addition, the IAN canal was involved and compromised. B) CBCT scans 6 months after 
marsupialization (first surgical step): evidence of new bone formation, reappearance of cortical borders, both on the lingual and the vestibular side; 
volume cyst reduction and channelling of IAN canal. C) Radiographic control (CBCT) 12 months after enucleation (second surgical step) revealed 
almost complete remineralisation of the osteolytic area, with partial disappearance of the ostetomised and repositioned bone segment. D) CBCT 
scans taken 36 months from the surgical reintervention (third surgical approach): Evidence of complete repair of the bone defect, with rear-
rangement of the medullary bone, remineralisation of the cortical bone with complete canalisation of the mandibular canal and absence of re-
currences. CBCT Cone Beam Computed Tomography, IAN  Inferior Alveolar Nerve, UA  Unicystic Ameloblastoma. 
U. Consolo et al.                                                                                                                                                                                                       
Oral and Maxillofacial Surgery Cases 6 (2020) 100173
3
The histological report was compatible with a diagnosis of mural UA with a follicular pattern (Fig. 3A). Given the patient’s age and 
functional and aesthetic considerations, the marsupialization was maintained until the cortical rim of the mandibular canal had 
remineralised. 
At 2 months, the first post-marsupialization CBCT revealed reappearance of the cortical borders and bone neoformation. At 6 
months postoperatively, a second CBCT was performed, revealing further formation of new bone, a reduction in cystic volume and 
channelling of the IAN canal (Fig. 1B). 
A second surgery was then planned. A lateral corticotomy was performed, as described by Alling and Alling [6], to create a “bone 
door” to provide surgical access to the lesion, thereby allowing enucleation of the ameloblastoma, scraping off the bone walls to 
remove potential ameloblastic infiltrates and extraction of the impacted tooth. The “bone door” was then relocated to its original 
position using microplates and titanium screws (Fig. 4). The surgical specimen was sent for histological analysis. 
The pathologist confirmed the diagnosis of UA with mural growth and a follicular pattern (Fig. 3B). 
A CBCT,performed 6 months after the second surgery, showed progression of the osteoblastic process of bone repair. Another OPG 
was performed 1 year after the excision, which revealed almost complete mineralisation of the osteolytic area, with the exception of 
the bone surrounding the osteosynthesis plate and screws. On a third CBCT, the partial disappearance of the ostetomised and repo-
sitioned bone segment was evident and thus necessitating surgical reintervention. Additional findings included thorough ossification 
of the mandibular angle, both on the lingual and vestibular sides, but also a bone defect probably due to bone necrosis in the area of the 
plate and “bone door” (Fig. 1C). The osteosynthesis plate and screws were removed, and the inflammatory tissue was excised 
completely and sent for histological examination (Fig. 5). 
Microscopic results revealed odontogenic epithelium arranged in a follicular pattern with isolated foci of basaloid cells with pe-
ripheral palisading in the intraosseous portion of the bone defect. (Fig. 3C). 
Twelve months after the last surgery, CBCT demonstrated complete repair of the residual defect, with rearrangement of the 
medullary bone, remineralisation of cortical bone, complete canalisation of the mandibular canal and absence of suspicious lesions . 
The patient was followed up until 24 months after the third surgery. On OPG, complete healing of the lesion, thorough ossification 
of the defect, no signs of recurrence and maintenance of the mandibular angle and ramus profile were observed . Clinically, the 
therapeutic process resulted in the absence of deformity, no alteration in the mandibular contour and no functional alterations (with 
respect to either laterality or protrusion). The patient remained symptom-free and had no appreciable neurological damage to the IAN. 
CBCT performed 36 months after the third surgery showed no evidence of recurrence and confirmed the bone healing (Fig. 1D). 
Nonetheless, due to the aggressive behaviour of this UA subtype and risk of recurrence, the patient will be monitored closely by long- 
term clinical and radiological follow-up. 
3. Discussion 
The differential diagnosis of large unilocular osteolithic lesions must consider UA, keratocysts and odontogenic cysts, but a final 
diagnosis and thus the initiation of treatment can only be made following biopsy [7]. The incisional biopsy allowed us to marsupialise 
the lesion while waiting for the histological result. Marsupialization is very effective in the molar area and mandibular ramus due to the 
bone structure and local anatomy. The healing potential of the marsupialised lesion depends on the rate of new bone regeneration, 
Fig. 2. Clinical images of the first surgical approach performed in order to biopsy the lesion. A) Removal of a portion of the cystic wall, harvested for 
histological examination. B) The cystic cavity, was periodically irrigated with hydrogen peroxide (10 vol)/chlorhexidine (0.2%). C) The cavity was 
filled with gentamicin-soaked gauze to maintain patency. 
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which is related to the patient’s age and site of the pathology [8]. Among the factors that affect the marsupialization outcome are the 
surgical technique and tumour growth pattern [8]. Nakamura et al. [9] described two main histological patterns relevant to the 
pathological behaviour of the tumour: expansive lesions, which remain confined within their capsulated borders, and invasive lesions, 
Fig. 3. Histological images of the collected samples. A) Sample at first surgical step: Hematoxylin and Eosin (H&E), 4x. Odontogenic epithelium 
arranged in follicular pattern. Variably sized clusters of cells composed of central loosely arranged areas with basal cell components, surrounded by 
columnar epithelial cells with clear and vacuolated cytoplasm and hyperchromatic nuclei. Nuclei were aligned at the periphery away from the 
basement membrane. Absence of significant nuclear pleomorphism and inconspicuous mitotic activity. Microcyst changes were appreciable as well 
as minimal stroma with moderate fibrous tissue component. B) Sample at the second surgical step. Hematoxylin and Eosin (H&E), 4x. Odontogenic 
epithelium arranged in follicular pattern. Sheets and nests of basoloid cells with peripheral palisading were evident. The cells showed hyper-
chromatic nuclei and reduced mitotic activity. The remaining mucosa presented ulcerated areas with chronic inflammation. C) Sample at the third 
surgical step. Hematoxylin and Eosin (H&E), 4x. Odontogenic epithelium is arranged in follicular pattern. Isolated foci of basaloid cells with pe-
ripheral palisading. Stroma presented marked reactive fibrous tissue components. 
Fig. 4. Clinical images of the second surgery performed to enucleate the lesion. A) Vision of the cortical bone at the initial phase of the surgery. B) 
Fixing of the microplate with titanium screws in order to create a guide for relocating the ostetomized bone. C) Lateral corticotomy performed using 
piezoelectric instruments. D) Vision of the mandibular segment after ameloblastoma enucleation, scraping of the bone walls to remove potential 
ameloblastic infiltrates and extraction of the impacted tooth (4.8). E) Reposition of the removed bone portion using a microplate and titanium 
screws for fixation. 
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which microscopically invade the surrounding bone outside their fibrotic capsules. The expansive subtype is usually more responsive 
to marsupialization, whereas the invasive subtype requires a more radical approach involving complete resection. The ameloblastic 
mandibular lesion in this case had a unilocular aspect with well-demarcated borders, consistent with a diagnosis of UA. However, it 
also included an outer layer of basaloid cells [9] and cortical bone perforation [10], both of which are associated with a worse 
prognosis [10]. Other negative predictive factors are the surgical approach, radiographic appearance, tumour size and histologic 
subtype [11,12]. Multicystic lesions, especially the follicular subtype, and unicystic mural lesions are frequently associated with 
recurrence [11]. 
The histological result in the presented case was UA with mural growth. According to the literature [1,4,5,12,13], given its risk of 
recurrence, UA with mural proliferation resembles CA more closely than UA. Mural ameloblastoma managed by surgical enucleation 
alone or in association with curettage has a recurrence rate of 35.7% [14], while the radical approach gives a very low risk of 
recurrence [4], and a 1-cm safety margin minimises the risk [5] . 
Based on the size of the lesion, the aim of surgery is to maintain the continuity of the mandible or achieve complete (partial or total) 
resection that can be managed by reconstruction with osteosynthesis plates alone or osteosynthesis plates plus bone grafts. In case of 
mandible discontinuity, treatment could result in anaesthetic deformities, facial asymmetry, dysfunctional mouth opening and 
chewing defects and thereby a reduced quality of life [1]. For this reason, some authors suggest a conservative approach for patients 
likely to comply with the demands of a long postoperative follow-up [15,16]. 
Our patient was initially managed conservatively to maintain the lower mandibular border as much as possible, reconstruct the 
vestibular and lingual cortical bone and regain the cortical rim of the mandibular canal. This approach facilitated the second surgical 
step while maintaining nerve integrity and function [16]. 
In patients treated with radical or conservative approaches, the aim of postoperative follow-up should be preventing relapse to 
avoid the need for radical re-intervention. 
In our experience, follow-up is conducted as long as possible regardless of the surgical treatment. This protocol includes CBCT 
performed 1 year after surgery and OPG once a year until 5 years after surgery. OPG is then repeated every 3 years in patients with UA 
and every 2 years in those with CA or ameloblastoma with mural invasion. Suspected recurrence should be evaluated by CBCT. 
4. Conclusions 
Although mural ameloblastoma represents a variant of UA, its aggressiveness and similar recurrence rate to that of CA indicate the 
need for radical treatment. Nonetheless, in some patients, conservative treatment is a valid alternative and can preserve aesthetic 
functions and outcomes as well as quality of life. These approaches demand patient compliance and strict radiographic follow-up. In 
the case reported herein, good functional and aesthetic outcomes were achieved, and no relapse was observed at 3 years after surgery. 
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Fig. 5. Clinical images from the third surgical step: A) The previously relocated bone wall appears necrotic upon flap elevation. B) Details of the 
necrotic bone after fixation-plate removal. C) Excision of the inflammatory tissue incapsulating the necrotic segment. D) Vision of the mandibular 
ramus after necrotic bone and inflammatory tissue excision, performed along with scraping of the bone walls in the attempt of removing potential 
ameloblastic infiltrates. 
U. Consolo et al.                                                                                                                                                                                                       
Oral and Maxillofacial Surgery Cases 6 (2020) 100173
6
Consent statement 
Formal consent for the publication was not elaborated and obtained because the figures used are completely anonymized and 
without any marks that can make the patient identificable. 
Declaration of competing interest 
The authors declare no conflict of interest. 
Acknowledgments 
The English in this document has been checked by at least two professional editors, both native speakers of English. For a cer-
tificate, please see: http://www.textcheck.com/certificate/ANe4IH. 
References 
[1] Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis 2018;24:307–16. 
[2] Ackermann GL, Altini M, Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol 1988;17(9-10):541–6. 
[3] Li TJ, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 1995;26(3): 
219–28. 
[4] Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF. Ameloblastoma: a surgeon’s dilemma. J Oral Maxillofac Surg 2006;64(7):1010–4. 
[5] Giraddi GB, Arora K, Saifi AM. Ameloblastoma: a retrospective analysis of 31 cases. J Oral Biol Craniofac Res 2017;7(3):206–11. 
[6] Alling R, Alling III CC. Removal of impacted teeth and lesion from unusual locations. Oral Maxillofac Surg Clin 1993;5:111–9. 
[7] Kim J, Nam E, Yoon S. Conservative management (marsupialization) of unicystic ameloblastoma: literature review and a case report. Maxillofac Plast Reconstr 
Surg 2017 25;39(1):38. 
[8] Nakamura N, Higuchi Y, Tashiro H, Ohishi M. Marsupialization of cystic ameloblastoma: a clinical and histopathologic study of the growth characteristics before 
and after marsupialization. J Oral Maxillofac Surg 1995;53(7):748–54. 
[9] Nakamura N, Higuchi Y, Mitsuyasu T, Sandra F, Ohishi M. Comparison of long-term results between different approaches to ameloblastoma. Oral Surg Oral Med 
Oral Pathol Oral Radiol Endod 2002;93(1):13–20. 
[10] Zheng CY, Cao R, Hong WS, Sheng MC, Hu YJ. Marsupialisation for the treatment of unicystic ameloblastoma of the mandible: a long-term follow up of 116 
cases. Br J Oral Maxillofac Surg 2019;57(7):655–62. 
[11] Almeida Rde A, Andrade ES, Barbalho JC, Vajgel A, Vasconcelos BC. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic 
review and meta-analysis. Int J Oral Maxillofac Surg 2016;45(3):359–67. 
[12] Au SW, Li KY, Choi WS, Su YX. Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg 2019;48(10): 
1300–6. 
[13] Chouinard AF, Peacock ZS, Faquin WC, Kaban LB. Unicystic ameloblastoma revisited: comparison of Massachusetts general hospital outcomes with original 
robinson and martinez report. J Oral Maxillofac Surg 2017;75(11):2369–78. 
[14] Li TJ, Wu YT, Yu SF, Yu GY. Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients. Am J Surg Pathol 2000;24(10):1385–92. 
[15] Hammarfjord O, Roslund J, Abrahamsson P, Nilsson P, Thor A, Magnusson M, Kjeller G, Englesson-Sahlstrom C, Strandkvist T, Warfvinge G, Krüger-Weiner C. 
Surgical treatment of recurring ameloblastoma, are the options? Br J Oral Maxillofac Surg 2013;51:762–6. 
[16] Hasegawa T, Imai Y, Takeda D, Yasuoka D, Ri S, Shigeta T, Minamikawa T, Shibuya Y, Komori T. Retrospective study of ameloblastoma: the possibility of 
conservative treatment. Kobe J Med Sci 2013;59(4):E112–21. 
U. Consolo et al.                                                                                                                                                                                                       
